Related Experiment Video
Updated: Feb 28, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Atrial Septal Defect Increases the Risk for Stroke After Total Hip Arthroplasty
Dean C Perfetti1, Morad Chughtai2, Matthew R Boylan3
1Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, New York.
Insights
Patients with atrial septal defect (ASD) or patent foramen ovale (PFO) undergoing total hip arthroplasty (THA) face a significantly higher risk of perioperative acute ischemic stroke (AIS). This highlights the need for pre-operative risk discussion.
Area of Science:
- Cardiology
- Orthopedic Surgery
- Neurology
Background:
- Atrial septal defect (ASD) and patent foramen ovale (PFO) are common congenital heart conditions.
- These defects pose risks for perioperative acute ischemic stroke (AIS) via paradoxical emboli.
Purpose of the Study:
- To determine ASD/PFO prevalence in total hip arthroplasty (THA) patients.
- To assess perioperative AIS rates in THA patients with ASD/PFO.
- To compare AIS risk in THA patients with ASD/PFO versus controls.
Main Methods:
- Analysis of 393,652 THA patients from the Nationwide Inpatient Sample (2007-2013).
- Identification of ASD/PFO and perioperative AIS using ICD-9-CM codes.
- Propensity score matching of 252 ASD/PFO patients with 756 controls.
Main Results:
- ASD/PFO prevalence was 64 per 100,000 THA patients.
- AIS rate was 7.14% in ASD/PFO patients vs. 0.26% in controls (P < .001).
- ASD/PFO increased AIS risk by 29-fold (OR, 29.00; P < .001).
Conclusions:
- THA patients with ASD/PFO have substantially elevated perioperative AIS risk.
- Orthopedic surgeons must discuss this risk pre-operatively.
- Further research is needed on thromboprophylaxis for ASD/PFO patients.
Background:
Atrial septal defect (ASD) and patent foramen ovale (PFO) are 2 of the most common congenital heart diseases in adults and pose important risks of perioperative acute ischemic stroke (AIS) from paradoxical emboli. We evaluated the following: (1) the prevalence of ASD/PFO in the total hip arthroplasty (THA) population; (2) the rate of perioperative AIS during index admissions; and (3) the risk for perioperative AIS after THA for patients with ASD/PFO vs matched controls.
Methods:
We identified 393,652 patients in the Nationwide Inpatient Sample who underwent THA between January 1, 2007, and December 31, 2013. The International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes were used to identify patients with ASD/PFO and perioperative AIS. Propensity scores matched 252 patients with ASD/PFO to 756 controls (3:1 ratio) without ASD/PFO according to age, gender, race, Deyo comorbidity score, year of surgery, and stroke risk factors. Logistic regression models assessed risk for perioperative AIS.
Results:
The prevalence of ASD/PFO was 64 per 100,000 THA patients. The rate of perioperative AIS was 99 per 100,000 THA in the general THA population. The rate of perioperative AIS was 7.14% for ASD/PFO patients compared with 0.26% in matched controls (P < .001). Risk for perioperative AIS was 29 times greater for patients with ASD/PFO compared with matched controls (odds ratio, 29.00; 95% confidence interval, 6.68-125.89; P < .001).
Conclusion:
Patients with ASD/PFO undergoing THA are at a significantly higher risk of perioperative AIS. Orthopedic surgeons should discuss this risk with patients before surgery. The efficacy of mechanical and pharmacologic thromboprophylactic measures to reduce perioperative AIS among ASD/PFO patients warrants further investigation.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Aneurysm III: Interprofessional Care
Mitral Stenosis I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management

